Moreover, exogenous IL-33 treatment can increase the neutrophil influx into the peritoneal cavity, which contributes to enhancing bacterial clearance in the site of infection and reducing mortality in mice with sepsis from CLP [48]. This evidence concerns the gene IL33 and Sepsis.